Cargando…

P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES

Detalles Bibliográficos
Autores principales: Taghi Khani, A., Kumar, A., Radecki, K., Lee, S. J., Sanchez Ortiz, A., Lorenson, M., Wu, X., Koff, J., Forman, S., Gu, Z., Walker, A., Swaminathan, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429344/
http://dx.doi.org/10.1097/01.HS9.0000848048.13001.58